Literature DB >> 1417052

Management of hypertensive emergencies.

J E Deal1, T M Barratt, M J Dillon.   

Abstract

Between 1975 and 1985, 454 patients with hypertension were admitted to the Renal Unit of the Hospital for Sick Children. A total of 110 (24%) patients presented with severely raised blood pressures deemed to require emergency management. At presentation 84/110 had symptoms and signs of long standing hypertension with neurological involvement. Between 1975 and 1980 bolus intravenous injections of diazoxide and/or hydralazine were used with the aim of reducing the blood pressure to within the normal range for age in the first 12-24 hours after admission. Of 57 patients treated in this way 13 developed hypotensive complications and four, whose blood pressures returned to normal within 24 hours of admission, suffered irreversible neurological damage. Subsequently, the management changed to the use of intravenous infusions of labetalol (1-3 mg/kg/hour) and/or sodium nitroprusside (0.5-8 micrograms/kg/min) to enable a more gradual controlled reduction of blood pressure over the first 96 hours of admission. Between 1980 and 1985, 53 patients were treated using this regimen. In all cases blood pressure reduction was achieved in a more controlled manner without further neurological impairment or serious irreversible side effects. From our experience, the use of labetalol and sodium nitroprusside by incremental infusion in the critical early phase of management has resulted in improved control of accelerated hypertension without the sudden hypotensive episodes seen when bolus injections are used.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1417052      PMCID: PMC1793638          DOI: 10.1136/adc.67.9.1089

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  16 in total

1.  Comparison of sublingual captopril and nifedipine in immediate treatment of hypertensive emergencies. A randomized, single-blind clinical trial.

Authors:  P Angeli; M Chiesa; L Caregaro; C Merkel; D Sacerdoti; M Rondana; A Gatta
Journal:  Arch Intern Med       Date:  1991-04

2.  Captopril in hypertensive crisis.

Authors:  J H Hauger-Klevene
Journal:  Lancet       Date:  1985-09-28       Impact factor: 79.321

3.  Intravenous labetalol in hypertensive emergency.

Authors:  A M Cumming; D L Davies
Journal:  Lancet       Date:  1979-04-28       Impact factor: 79.321

4.  Oral converting enzyme inhibitor in malignant hypertension.

Authors:  W Griswold; R McNeal; D O'Connor; V Reznik; S Mendoza
Journal:  Arch Dis Child       Date:  1982-03       Impact factor: 3.791

5.  Cerebral complications in the treatment of accelerated hypertension.

Authors:  J G Ledingham; B Rajagopalan
Journal:  Q J Med       Date:  1979-01

6.  Intravenous labetalol in the management of severe hypertension and hypertensive emergencies.

Authors:  M D Cressman; D G Vidt; R W Gifford; W S Moore; D J Wilson
Journal:  Am Heart J       Date:  1984-05       Impact factor: 4.749

7.  Nifedipine in hypertensive emergencies of children.

Authors:  U Dilmen; M K Cağlar; D A Senses; E Kinik
Journal:  Am J Dis Child       Date:  1983-12

8.  Sodium nitroprusside treatment of severe arterial hypertension in children.

Authors:  G Gordillo-Paniagua; L Velásquez-Jones; R Martini; E Valdez-Bolaños
Journal:  J Pediatr       Date:  1975-11       Impact factor: 4.406

9.  Blindness and paraplegia in severe childhood hypertension.

Authors:  J A Hulse; D S Taylor; M J Dillon
Journal:  Lancet       Date:  1979-09-15       Impact factor: 79.321

10.  Infarction of the optic nerve head in children with accelerated hypertension.

Authors:  D Taylor; J Ramsay; S Day; M Dillon
Journal:  Br J Ophthalmol       Date:  1981-03       Impact factor: 4.638

View more
  19 in total

1.  Hypertensive emergencies in children.

Authors:  Pankaj Hari; Aditi Sinha
Journal:  Indian J Pediatr       Date:  2011-01-27       Impact factor: 1.967

2.  Evaluation of the safety and efficacy of metoprolol infusion for children and adolescents with hypertensive crises: a retrospective case series.

Authors:  Rola Saqan; Hanan Thiabat
Journal:  Pediatr Nephrol       Date:  2017-07-21       Impact factor: 3.714

Review 3.  A diagnostic approach for the child with hypertension.

Authors:  Natasa Marcun Varda; Alojz Gregoric
Journal:  Pediatr Nephrol       Date:  2005-02-19       Impact factor: 3.714

Review 4.  Evaluation and Management of Stage 2 Hypertension in Pediatric Patients.

Authors:  Yosuke Miyashita; Coral Hanevold
Journal:  Curr Hypertens Rep       Date:  2018-07-06       Impact factor: 5.369

Review 5.  Evaluation and management of elevated blood pressures in hospitalized children.

Authors:  Abanti Chaudhuri; Scott M Sutherland
Journal:  Pediatr Nephrol       Date:  2018-08-31       Impact factor: 3.714

6.  Hypertensive crisis in children and adolescents.

Authors:  Tomáš Seeman; Gilad Hamdani; Mark Mitsnefes
Journal:  Pediatr Nephrol       Date:  2018-10-01       Impact factor: 3.714

Review 7.  Comparative tolerability profile of hypertensive crisis treatments.

Authors:  E Grossman; A N Ironi; F H Messerli
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606

Review 8.  Clinical pharmacokinetics of vasodilators. Part I.

Authors:  R Kirsten; K Nelson; D Kirsten; B Heintz
Journal:  Clin Pharmacokinet       Date:  1998-06       Impact factor: 6.447

Review 9.  Treatment of hypertension in children.

Authors:  A R Sinaiko
Journal:  Pediatr Nephrol       Date:  1994-10       Impact factor: 3.714

Review 10.  Severe hypertension in children and adolescents: pathophysiology and treatment.

Authors:  Joseph T Flynn; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2008-10-07       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.